Michael Scolaro

Michael Scolaro

Oct 18, 2017

Group 6 Copy 44
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis

    Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...

    A scientific approach to placenta remedies: What hormones are found in placenta tissue?

    The human placenta contains a mixture of substances which may be useful for individual postpartum treatment...

    Do Pacific Northwest marine mammals carry antibiotic-resistant bacteria from land animals?

    Antibiotic resistance, a global concern, is a significant health issue of animals and humans. Resistant...

    Backer Badge Funded